Xanthine oxidoreductase inhibitor topiroxostat ameliorates podocyte injury by inhibiting the reduction of nephrin and podoplanin Ying Zhang; Yoshiyasu Fukusumi; Mutsumi Kayaba; Takashi Nakamura; Ryusuke Sakamoto; Naoki Ashizawa; Hiroshi Kawachi;

Does uric acid-lowering treatment slow the progression of chronic kidney disease? A meta-analysis of randomized controlled trials Paulo Roberto Bignardi; Danielle Harumi Ido; Felipe Augusto Lopes Garcia; Lucas Mendes Braga; Vinicius Daher Alvares Delfino;

Consideraciones acerca de las bases moleculares de algunas tubulopatías en relación con la endogamia y los desplazamientos poblacionales Víctor M. García-Nieto; Félix Claverie-Martín; Ana Perdomo-Ramírez; Elizabeth Cárdoba-Lanus; Elena Ramos-Trujillo; Glorián Mura-Escorche; Patricia Tejera-Carreño; María I. Luis-Yanes;